Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-05-24
1997-11-18
Loring, Susan A.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241551, 4241411, 4241581, 4241741, 4241561, 5303881, 5303882, 53038825, 5303888, 53038885, A61K 39395, C07K 1600, C07K 1618, C07K 1630
Patent
active
056885059
ABSTRACT:
The present invention provides a low cost, less toxic, anti-cancer immunotherapy which enhances the host's immune system ability to destroy or contain cancers, and also provides a diagnostic test for cancer. Specifically, the present invention provides monoclonal antibodies specific for, that is, specifically bind, oncofetal protein (OFP), a cancer cell product. Tumors treated with a single dose of the monoclonal antibodies against OFP are markedly reduced in size, and leukemic populations of cells treated with a single does of monoclonal antibodies against OFP are significantly decreased in number. Since the monoclonal antibodies of the present invention do not bind to tumor cells, the monoclonal antibody treatment overcomes the disadvantages associated with tumor cell targeting. Monoclonal antibodies to OFP offer a simple and inexpensive agent for use as a primary or adjuvant therapy against a wide variety of cancers and tumors in humans and other animals. The monoclonal antibodies against OFP are also employed to detect cancer in animal, including human patients.
REFERENCES:
patent: 4746539 (1988-05-01), Webb et al.
patent: 4871661 (1989-10-01), Webb et al.
patent: 5310653 (1994-05-01), Hanausek-Walazek et al.
Steve Runge's thesis "Characterization of an Oncofetal Protein (OFP) and Cloning of its cDNA" pp. 76-113, cataloged at Ohio State University, Jul. 30, 1992.
Oredipe, O.A., et al. Carcinogenesis, 10(12): 2175-2181, Dec., 1989.
Abstract #1311, Schumm, D.E., Proc. Ann. Meet. Am.Assoc. Ca. Res. 33:A1311, Mar. 1992.
Abstract #1515, Schum, D.E., et al. "Characteristics of an Oncofetal Tumor Marker Protein", Proc. Am. Assoc. Ca. Res. 31: 256, Mar. 1990.
Abstract #1669, Runge, S.W., et al., "Characterization of an Oncofetal Protein (OFP) and Cloning of its cDNA," Proc. Am. Assoc., Ca. Res. 32: Mar. 1991.
Abstract #7502, Runge, S.W., et al., "Characterization of an Oncofetal Protein (OFP) and Cloning of Its cDNA", 75th Annual Meeting of Assoc. of Biochem. and Mol. Biol. FASEB, Apr. 1991.
Runge, S., et al. "Development and Use of Monoclonal Antibodies Against an Oncofetal Protein Associated with Carcinogenesis and Tumorgenesis" Immunological Investigation, 20(3):269-286 (1991).
Stomberg, Paul C., et al. "Expression of an Oncofetal Protein (OFP) in Rat and Human Leukemia Cells", Leukemia Research, vol. 15, pp. 427-433 (1991).
Schumm Dorothy E.
Stromberg Paul C.
Webb Thomas E.
Loring Susan A.
The Ohio State University
LandOfFree
Method for treating cancer with monoclonal antibodies to oncofet does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating cancer with monoclonal antibodies to oncofet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating cancer with monoclonal antibodies to oncofet will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1563740